AIM ImmunoTech Announces $2.65 Million Financing Priced At-Market under NYSE American Rules

OCALA, Fla., June 09, 2026 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced that it has entered into definitive agreements for a registered direct offering and concurrent private placement priced at-the-market under NYSE American rules for gross proceeds of approximately $2.65 million, before deducting placement agent commissions and other offering […]

June 9, 2026

Biofrontera Inc.: A Dermatology Company Scaling with Momentum

April 8, 2026

Syntec Optics (Nasdaq: OPTX) Secures $4.6M Critical-Care Biomedical Order

ROCHESTER, NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) — Syntec Optics (Nasdaq: OPTX), a leading innovator in defense tech, space tech, and biomedical tech manufacturing, today announced a new $4.6 million purchase order for the continued manufacturing of advanced laser blood-test cartridges and optical reader subsystems for benchmark instrumentation used across global clinics and hospitals. “As […]

June 9, 2026

Aditxt Signed Definitive Agreement Valuing Ignite Proteomics at Approximately $150 Million

Transaction values Ignite Proteomics at approximately $150 million and is expected to position Ignite as an independent NYSE-listed functional proteomics company, while Aditxt continues as a separate Nasdaq-listed company MOUNTAIN VIEW, Calif. & GOLDEN, Colo. & HONG KONG–(BUSINESS WIRE)–Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt”), a qualified acquisition corp and Ignite Proteomics, LLC (“Ignite”, or “Ignite Proteomics”), […]

June 9, 2026